PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer Clinical Trials in Shanghai, Shanghai Municipality

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer